dc.contributor.author | Elwakeel, Eiman | |
dc.contributor.author | Brüne, Bernhard | |
dc.contributor.author | Weigert, Andreas | |
dc.date.accessioned | 2023-05-09T17:13:28Z | |
dc.date.available | 2023-05-09T17:13:28Z | |
dc.date.issued | 2019-08 | |
dc.identifier.issn | 1098-8823 | |
dc.identifier.uri | https://hdl.handle.net/1721.1/150660 | |
dc.description.sponsorship | National Institutes of Health (NIH) | en_US |
dc.publisher | Elsevier BV | en_US |
dc.relation.isversionof | 10.1016/j.prostaglandins.2019.106339 | en_US |
dc.rights | Creative Commons Attribution-Noncommercial-NoDerivatives | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | en_US |
dc.source | Eiman Elwakeel | en_US |
dc.subject | Cell Biology | en_US |
dc.subject | Pharmacology | en_US |
dc.subject | Physiology | en_US |
dc.subject | Biochemistry | en_US |
dc.title | PGE2 in fibrosis and cancer: Insights into fibroblast activation | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Elwakeel, Eiman, Brüne, Bernhard and Weigert, Andreas. 2019. "PGE2 in fibrosis and cancer: Insights into fibroblast activation." Prostaglandins & Other Lipid Mediators, 143. | |
dc.relation.journal | Prostaglandins & Other Lipid Mediators | en_US |
dc.eprint.version | Author's final manuscript | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.identifier.doi | https://doi.org/10.1016/j.prostaglandins.2019.106339 | |
dspace.date.submission | 2023-05-01T19:59:29Z | |
mit.journal.volume | 143 | en_US |
mit.license | PUBLISHER_CC | |
mit.metadata.status | Authority Work and Publication Information Needed | en_US |